and Eli Lilly's Trulicity (dulaglutide). Semaglutide is also being developed as a once-weekly injection that has already been shown to provide good control of blood glucose in phase III trials ...
"Johnson & Johnson and Mitsubishi Tanabe Pharma’s Stelara (ustekinumab) and Eli Lilly and Sumitomo Dainippon Pharma’s Trulicity (dulaglutide) are ranked ninth and tenth,” Sabaratnam says.
Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed ...
Am J Health Syst Pharm. 2007;64(12):1265-1273.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback